Fast, Capital-Efficient Companies with Innovative Vascular Treatments
We’re accelerating lean and nimble interventional vascular companies that are developing devices for addressable markets of over $10 billion.
FastWave is Rapidly Building Better IVL Catheters
The FastWave team is building cost-effective intravascular lithotripsy (IVL) balloon catheters engineered to cross difficult lesions with superior pushability and smooth performance. Big Sky partners rocketed FastWave to a milestone-based acquisition with a global strategic within 6 months of forming the company.
Crossfire’s Differentiated Approach to Thermal & NTNT Catheters
Crossfire’s exceptional team is accelerating the development of non-thermal, non-tumescent (NTNT) catheters and an economic thermal endovenous ablation system that’s optimized for procedural efficiency. Incubated out of Big Sky, Crossfire is poised for regulatory clearance and commercial launch at a record-breaking pace.